Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Orthopediatrics (KIDS) over the last 10 years, with Q3 2025 value amounting to -$11.8 million.

  • Orthopediatrics' Net Income towards Common Stockholders fell 4866.78% to -$11.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$45.6 million, marking a year-over-year decrease of 6036.42%. This contributed to the annual value of -$37.8 million for FY2024, which is 8032.8% down from last year.
  • As of Q3 2025, Orthopediatrics' Net Income towards Common Stockholders stood at -$11.8 million, which was down 4866.78% from -$7.1 million recorded in Q2 2025.
  • In the past 5 years, Orthopediatrics' Net Income towards Common Stockholders registered a high of $18.5 million during Q3 2022, and its lowest value of -$16.1 million during Q4 2024.
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$6.8 million (2023), whereas its average is -$5.4 million.
  • Data for Orthopediatrics' Net Income towards Common Stockholders shows a peak YoY increase of 94383.25% (in 2022) and a maximum YoY decrease of 1100000.0% (in 2022) over the last 5 years.
  • Over the past 5 years, Orthopediatrics' Net Income towards Common Stockholders (Quarter) stood at $72000.0 in 2021, then tumbled by 11000.0% to -$7.8 million in 2022, then rose by 14.74% to -$6.7 million in 2023, then tumbled by 140.16% to -$16.1 million in 2024, then grew by 26.73% to -$11.8 million in 2025.
  • Its Net Income towards Common Stockholders stands at -$11.8 million for Q3 2025, versus -$7.1 million for Q2 2025 and -$10.7 million for Q1 2025.